PUBLIC HEALTH IMPACT OF NIRSEVIMAB AGAINST LOWER RESPIRATORY INFECTIONS ASSOCIATED WITH RESPIRATORY SYNCYTIAL VIRUS AMONG CHINESE INFANTS

被引：0
|
作者：
Lai, X. [1 ]
Ma, Y. [2 ]
Zou, W. [3 ]
Soudani, S. [4 ]
Fang, H. [2 ]
机构：
[1] Peking Univ, Oxford, England
[2] Peking Univ, Beijing, Peoples R China
[3] Sanofi, Beijing, Peoples R China
[4] Sanofi, Lyon, France
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EPH206
引用
收藏
页码：S241 / S241
页数：1
相关论文
共 50 条
  • [1] Will nirsevimab be the holy grail for prevention of respiratory syncytial virus lower respiratory tract infections in infants?
    Homaira, Nusrat
    TRANSLATIONAL PEDIATRICS, 2024, 13 (03) : 525 - 529
  • [2] Does nirsevimab prevent lower respiratory infections caused by respiratory syncytial virus?
    Sullivan, Kelsey
    Sullivan, Brynne
    JOURNAL OF PERINATOLOGY, 2024, 44 (05) : 767 - 769
  • [3] Cost-Effectiveness and Public Health Impact of Universal Prophylaxis with Nirsevimab Against Respiratory Syncytial Virus (RSV) Infections in all Infants in Japan
    Shinichi Noto
    Alexia Kieffer
    Samira Soudani
    Takeshi Arashiro
    Chiho Tadera
    Sebastien Eymere
    Tobiasz Lemański
    Xinyu Wang
    Infectious Diseases and Therapy, 2025, 14 (4) : 847 - 865
  • [4] Respiratory syncytial virus - associated lower respiratory tract infections in hospitalized infants
    D'Elia, C
    Siqueira, MM
    Portes, SA
    Sant'Anna, CC
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2005, 38 (01) : 7 - 10
  • [5] Nirsevimab for prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and Infants
    不详
    AUSTRALIAN PRESCRIBER, 2024, 47 (03) : 102 - 103
  • [6] DISTRIBUTION OF NIRSEVIMAB FOR RESPIRATORY SYNCYTIAL VIRUS PROPHYLAXIS AMONG INFANTS IN HAWAII
    Ueoka, A.
    Kimata, C.
    Siu, A.
    Ramsey, Wong K.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2025, 73 (01) : 477 - 479
  • [7] Nirsevimab Immunization to Prevent Respiratory Syncytial Virus-Associated Lower Respiratory Tract Infections in Infants and Children up to 24 Months of Age
    Cieslak, Chelsea M.
    NURSING FOR WOMENS HEALTH, 2024, 28 (01) : 75 - 79
  • [8] Nirsevimab effectiveness against hospital admission for respiratory syncytial virus bronchiolitis in infants
    Rodriguez-Fernandez, Rosa
    Gonzalez-Martinez, Felipe
    Velazquez, Ines Ojeda
    Diaz, Marta Rodriguez
    Bucciol, Maria Victoria Capozzi
    Gonzalez-Sanchez, Maria Isabel
    Perez-Moreno, Jimena
    del Castillo, Blanca Toledo
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2024, 37 (06)
  • [9] MODELED IMPACT OF NIRSEVIMAB AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV) AMONG UK INFANTS EXPERIENCING THEIR FIRST RSV SEASON
    Beuvelet, M.
    Davidson, C.
    Hudson, R.
    Kieffer, A.
    VALUE IN HEALTH, 2022, 25 (01) : S125 - S125
  • [10] Estimated Effectiveness of Nirsevimab Against Respiratory Syncytial Virus
    Xu, Hanmeng
    Aparicio, Camila
    Wats, Aanchal
    Araujo, Barbara L.
    Pitzer, Virginia E.
    Warren, Joshua L.
    Shapiro, Eugene D.
    Niccolai, Linda M.
    Weinberger, Daniel M.
    Oliveira, Carlos R.
    JAMA NETWORK OPEN, 2025, 8 (03)
12345